Share Prices & Company Research

Market News

26 Jan 2021 | 10:56

German health ministry dismisses claims about AstraZeneca vaccine efficacy

(Sharecast News) - The German health ministry has moved to refute speculation about the effectiveness of AstraZeneca's Covid-19 vaccine in older people. In a statement on Tuesday, it said there was no data suggesting an efficacy of only 8% among people aged over 65, as had previously been reported by some German media outlets.

Instead it said a study of the vaccine - which has been jointly developed by AstraZeneca and Oxford University - had been misread, and that the 8% figure referred instead to the number of people in the study aged between 56 and 69 years.

"At first glance it seems that two things were confused in the reports: around 8% of the subjects in the AstraZeneca effectiveness study were between 56 and 69 years, only 3% to 4% over 70 years. However, this does not indicate efficacy of only 8% among older people," The Express quoted the ministry as saying.

It also reiterated that it expected the European Medicines Agency to decide on Friday whether or not to approve the vaccine, according to Reuters.

AstraZeneca has already stated that the reports are "completely incorrect".
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.